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REPLY
I appreciate Dr. Kessler’s interest in our guidelines (1) and his
thoughtful comments about the importance of data to support
evidence-based clinical recommendations. This is precisely why
the expert panel assigned a class and level of evidence to express the
strength of the recommendation and the amount of data to support
it. Although I agree that recommendations for drug interventions,
such as hormone therapy, should be supported by randomized
controlled trials, I do not agree that basic lifestyle recommenda-
tions such as not smoking, engaging in regular physical activity,
eating a primarily plant-based diet, and maintaining a healthy
weight, require randomized controlled trials to be given our
strongest recommendation for clinical practice. As noted, such
research may not be feasible or ethical. Moreover, a class I
recommendation has not historically precluded further research.
Dr. Geoffrey Rose, a founding father of modern cardiovascular
epidemiology, established the principle that randomized controlled
trials are not necessary for interventions that restore us to our
evolutionary norms. Given the burgeoning epidemic of obesity and
the well-documented adverse consequences of smoking in our
society, I hope Dr. Kessler would agree that interventions to
restore individuals to a heart-healthy lifestyle should be a top
priority for clinical practice and for public health.
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